Michael is a Biotech Associate at Grey Wolf Therapeutics. In his role, Michael supports management of intellectual property and external communications alongside R&D projects.
Michael obtained his MRes at Xi’an Jiaotong-Liverpool University in Suzhou, China. His Masters’ thesis, investigating the role of GITR signalling in macrophages, was carried out at Soochow University, Suzhou. Prior to this, Michael studied Pharmacology with Industrial Experience at The University of Manchester, during which he completed a placement year in the Cancer Immunotherapy and Immune Modulation department at Boehringer Ingelheim in Vienna, Austria. He has also had summer work experience at multiple other labs including The Sackler Institute of Pulmonary Pharmacology at King College London.